The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as granzyme B, granzyme A, or Bax.

 
Web www.patentalert.com

< Formulations comprising antisense nucleotides to connexins

< Pharmaceutical compositions and methods of using secreted frizzled related protein

> Thienopyrimidine-based inhibitors of the SRC family

> Pretargeting methods and compounds

~ 00289